VitamFero holds a proprietary vaccine platform and a unique know-how based on the establishment and use of live attenuated protozoan parasite strains. Perfectly described and controlled, these strains and their recombinant derivatives are the API of anti-infectious vaccines, currently developed mostly against certain animal and human parasitoses such as toxoplasmosis or malaria the prevention of which still represents huge medical unmet need.